|
Diabetes, Vol 48, Issue 6 1223-1229, Copyright © 1999 by American Diabetes Association
Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction
A Rabinovitch, W Suarez-Pinzon, K Strynadka, Q Ju, D Edelstein, M Brownlee, GS Korbutt and RV Rajotte
Department of Medicine, University of Alberta, Edmonton, Canada.
Apoptosis has been identified as a mechanism of pancreatic islet beta-cell
death in autoimmune diabetes. Proinflammatory cytokines are candidate
mediators of beta-cell death in autoimmune diabetes, and these cytokines
can induce beta-cell death by apoptosis. In the present study, we examined
whether transfection of human islet beta-cells with an anti-apoptotic gene,
bcl-2, can prevent cytokine-induced beta-cell destruction. Human islet
beta-cells were transfected by a replication-defective herpes simplex virus
(HSV) amplicon vector that expressed the bcl-2 gene (HSVbcl-2) and, as a
control, the same HSV vector that expressed a beta-galactosidase reporter
gene (HSVlac). Two-color immunohistochemical staining revealed that 95+/-3%
of beta-cells transfected with HSVbcl-2 expressed Bcl-2 protein compared
with 14+/-3% of beta-cells transfected with HSVlac and 19+/-4% of
nontransfected beta-cells. The bcl-2-transfected beta-cells were fully
protected from impaired insulin secretion and destruction resulting from
incubation for 5 days with the cytokine combination of interleukin
(IL)-1beta, tumor necrosis factor (TNF)-alpha, and interferon (IFN)-gamma.
In addition, the bcl-2-transfected islet cells were significantly protected
from cytokine-induced lipid peroxidation and DNA fragmentation. These
results demonstrate that cytokine-induced beta-cell dysfunction and death
involve mechanisms subject to regulation by an anti-apoptotic protein,
Bcl-2. Therefore, bcl-2 gene therapy has the potential to protect human
beta-cells in pancreatic islets, or islet grafts, from immune-mediated
damage in type 1 diabetes.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. D. Rivas-Carrillo, A. Soto-Gutierrez, N. Navarro-Alvarez, H. Noguchi, T. Okitsu, Y. Chen, T. Yuasa, K. Tanaka, M. Narushima, A. Miki, et al.
Cell-Permeable Pentapeptide V5 Inhibits Apoptosis and Enhances Insulin Secretion, Allowing Experimental Single-Donor Islet Transplantation in Mice
Diabetes,
May 1, 2007;
56(5):
1259 - 1267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Santangelo, P. Matarrese, R. Masella, M. C. Di Carlo, A. Di Lillo, B. Scazzocchio, E. Vecci, W. Malorni, R. Perfetti, and E. Anastasi
Hepatocyte growth factor protects rat RINm5F cell line against free fatty acid-induced apoptosis by counteracting oxidative stress
J. Mol. Endocrinol.,
January 1, 2007;
38(1):
147 - 158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Surendran, S. H. Kim, B. K. Jee, S. H. Ahn, P. Gopinathan, and C. W. Han
Anti-apoptotic Bcl-2 gene transfection of human articular chondrocytes protects against nitric oxide-induced apoptosis
J Bone Joint Surg Br,
December 1, 2006;
88-B(12):
1660 - 1665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Z. Luo and L. Luo
American Ginseng Stimulates Insulin Production and Prevents Apoptosis through Regulation of Uncoupling Protein-2 in Cultured {beta} Cells
Evid. Based Complement. Altern. Med.,
September 1, 2006;
3(3):
365 - 372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Costes, C. Broca, G. Bertrand, A.-D. Lajoix, D. Bataille, J. Bockaert, and S. Dalle
ERK1/2 Control Phosphorylation and Protein Level of cAMP-Responsive Element-Binding Protein: A Key Role in Glucose-Mediated Pancreatic {beta}-Cell Survival.
Diabetes,
August 1, 2006;
55(8):
2220 - 2230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. S. Narang and R. I. Mahato
Biological and biomaterial approaches for improved islet transplantation.
Pharmacol. Rev.,
June 1, 2006;
58(2):
194 - 243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Collier, P. T. Fueger, H. E. Hohmeier, and C. B. Newgard
Pro- and Antiapoptotic Proteins Regulate Apoptosis but Do Not Protect Against Cytokine-Mediated Cytotoxicity in Rat Islets and {beta}-Cell Lines.
Diabetes,
May 1, 2006;
55(5):
1398 - 1406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cnop, N. Welsh, J.-C. Jonas, A. Jorns, S. Lenzen, and D. L. Eizirik
Mechanisms of Pancreatic {beta}-Cell Death in Type 1 and Type 2 Diabetes: Many Differences, Few Similarities
Diabetes,
December 1, 2005;
54(suppl_2):
S97 - S107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Jensen, E. D Galsgaard, A. E Karlsen, Y. C Lee, and J. H Nielsen
STAT5 activation by human GH protects insulin-producing cells against interleukin-1{beta}, interferon-{gamma} and tumour necrosis factor-{alpha}-induced apoptosis independent of nitric oxide production
J. Endocrinol.,
October 1, 2005;
187(1):
25 - 36.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Allison, H. E. Thomas, T. Catterall, T. W. H. Kay, and A. Strasser
Transgenic Expression of Dominant-Negative Fas-Associated Death Domain Protein in {beta} Cells Protects against Fas Ligand-Induced Apoptosis and Reduces Spontaneous Diabetes in Nonobese Diabetic Mice
J. Immunol.,
July 1, 2005;
175(1):
293 - 301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Barbu, G. Akusjarvi, and N. Welsh
Adenoviral-Mediated Transduction of Human Pancreatic Islets: Importance of Adenoviral Genome for Cell Viability and Association with a Deficient Antiviral Response
Endocrinology,
May 1, 2005;
146(5):
2406 - 2414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D'Amico, H. Hui, N. Khoury, U. Di Mario, and R. Perfetti
Pancreatic {beta}-cells expressing GLP-1 are resistant to the toxic effects of immunosuppressive drugs
J. Mol. Endocrinol.,
April 1, 2005;
34(2):
377 - 390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hui, N. Khoury, X. Zhao, L. Balkir, E. D'Amico, A. Bullotta, E. D. Nguyen, A. Gambotto, and R. Perfetti
Adenovirus-Mediated XIAP Gene Transfer Reverses the Negative Effects of Immunosuppressive Drugs on Insulin Secretion and Cell Viability of Isolated Human Islets
Diabetes,
February 1, 2005;
54(2):
424 - 433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Chen, K. V. Salojin, Q.-S. Mi, M. Grattan, T. C. Meagher, P. Zucker, and T. L. Delovitch
Insulin-Like Growth Factor (IGF)-I/IGF-Binding Protein-3 Complex: Therapeutic Efficacy and Mechanism of Protection against Type 1 Diabetes
Endocrinology,
February 1, 2004;
145(2):
627 - 638.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Cao, Z. Gao, C. E. Robert, S. Greene, G. Xu, W. Xu, E. Bell, D. Campbell, Y. Zhu, R. Young, et al.
Pancreatic-Derived Factor (FAM3B), a Novel Islet Cytokine, Induces Apoptosis of Insulin-Secreting {beta}-Cells
Diabetes,
September 1, 2003;
52(9):
2296 - 2303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Jambal, S. Masterson, A. Nesterova, R. Bouchard, B. Bergman, J. C. Hutton, L. M. Boxer, J. E.-B. Reusch, and S. Pugazhenthi
Cytokine-mediated Down-regulation of the Transcription Factor cAMP-response Element-binding Protein in Pancreatic {beta}-Cells
J. Biol. Chem.,
June 13, 2003;
278(25):
23055 - 23065.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. V. Tran, G. Chen, C. B. Newgard, and H. E. Hohmeier
Discrete and Complementary Mechanisms of Protection of {beta}-Cells Against Cytokine-Induced and Oxidative Damage Achieved by bcl-2 Overexpression and a Cytokine Selection Strategy
Diabetes,
June 1, 2003;
52(6):
1423 - 1432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. K. Rehman, S. Bertera, R. Bottino, A. N. Balamurugan, J. C. Mai, Z. Mi, M. Trucco, and P. D. Robbins
Protection of Islets by in Situ Peptide-mediated Transduction of the Ikappa B Kinase Inhibitor Nemo-binding Domain Peptide
J. Biol. Chem.,
March 7, 2003;
278(11):
9862 - 9868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. O'Brien, Y. Huang, X. Geng, J. P. Dutz, and D. T. Finegood
Phagocytosis of Apoptotic Cells by Macrophages From NOD Mice Is Reduced
Diabetes,
August 1, 2002;
51(8):
2481 - 2488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Chen, Z. Yang, R. Wu, and J. L. Nadler
Lisofylline, a Novel Antiinflammatory Agent, Protects Pancreatic {beta}-Cells from Proinflammatory Cytokine Damage by Promoting Mitochondrial Metabolism
Endocrinology,
June 1, 2002;
143(6):
2341 - 2348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pastorale, M. Arata, A. Caminos, L. Bruno, J. Basabe, and H. Chemes
Effect of Modified Diabetic Splenocytes on Mice Injected with Multiple Low-Dose Streptozotocin
Experimental Biology and Medicine,
April 1, 2002;
227(4):
282 - 289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gunther, P. O. Berberat, M. Haga, S. Brouard, R. N. Smith, M. P. Soares, F. H. Bach, and E. Tobiasch
Carbon Monoxide Protects Pancreatic {beta}-Cells From Apoptosis and Improves Islet Function/Survival After Transplantation
Diabetes,
April 1, 2002;
51(4):
994 - 999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Van de Casteele, B. A. Kefas, Z. Ling, H. Heimberg, and D. G. Pipeleers
Specific Expression of Bax-{omega} in Pancreatic {beta}-Cells Is Down-Regulated by Cytokines before the Onset of Apoptosis
Endocrinology,
January 1, 2002;
143(1):
320 - 326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pileggi, R. D. Molano, T. Berney, P. Cattan, C. Vizzardelli, R. Oliver, C. Fraker, C. Ricordi, R. L. Pastori, F. H. Bach, et al.
Heme Oxygenase-1 Induction in Islet Cells Results in Protection From Apoptosis and Improved In Vivo Function After Transplantation
Diabetes,
September 1, 2001;
50(9):
1983 - 1991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rabinovitch, W. L. Suarez-Pinzon, K. Sooy, K. Strynadka, and S. Christakos
Expression of Calbindin-D28k in a Pancreatic Islet {beta}-Cell Line Protects against Cytokine-Induced Apoptosis and Necrosis
Endocrinology,
August 1, 2001;
142(8):
3649 - 3655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Embury, D. Klein, A. Pileggi, M. Ribeiro, S. Jayaraman, R. D. Molano, C. Fraker, N. Kenyon, C. Ricordi, L. Inverardi, et al.
Proteins Linked to a Protein Transduction Domain Efficiently Transduce Pancreatic Islets
Diabetes,
August 1, 2001;
50(8):
1706 - 1713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Federici, M. Hribal, L. Perego, M. Ranalli, Z. Caradonna, C. Perego, L. Usellini, R. Nano, P. Bonini, F. Bertuzzi, et al.
High Glucose Causes Apoptosis in Cultured Human Pancreatic Islets of Langerhans: A Potential Role for Regulation of Specific Bcl Family Genes Toward an Apoptotic Cell Death Program
Diabetes,
June 1, 2001;
50(6):
1290 - 1301.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
P. M. Larsen, S.J. Fey, M.R. Larsen, A. Nawrocki, H.U. Andersen, H. Kähler, C. Heilmann, M.C. Voss, P. Roepstorff, F. Pociot, et al.
Proteome Analysis of Interleukin-1{beta}-Induced Changes in Protein Expression in Rat Islets of Langerhans
Diabetes,
May 1, 2001;
50(5):
1056 - 1063.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. E. Mathews, R. T. Graser, A. Savinov, D. V. Serreze, and E. H. Leiter
Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: Role for beta cell-expressed resistance determinants
PNAS,
January 2, 2001;
98(1):
235 - 240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bonny, A. Oberson, S. Negri, C. Sauser, and D. F. Schorderet
Cell-Permeable Peptide Inhibitors of JNK: Novel Blockers of {beta}-Cell Death
Diabetes,
January 1, 2001;
50(1):
77 - 82.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Saldeen
Cytokines Induce Both Necrosis and Apoptosis via a Common Bcl-2-Inhibitable Pathway in Rat Insulin-Producing Cells
Endocrinology,
June 1, 2000;
141(6):
2003 - 2010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Karlsen, D. Pavlovic, K. Nielsen, J. Jensen, H. U. Andersen, F. Pociot, T. Mandrup-Poulsen, D. L. Eizirik, and J. Nerup
Interferon-{gamma} Induces Interleukin-1 Converting Enzyme Expression in Pancreatic Islets by an Interferon Regulatory Factor-1-Dependent Mechanism
J. Clin. Endocrinol. Metab.,
February 1, 2000;
85(2):
830 - 836.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Chen, H. E. Hohmeier, and C. B. Newgard
Expression of the Transcription Factor STAT-1alpha in Insulinoma Cells Protects against Cytotoxic Effects of Multiple Cytokines
J. Biol. Chem.,
January 5, 2001;
276(1):
766 - 772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E. Karlsen, S. G. Ronn, K. Lindberg, J. Johannesen, E. D. Galsgaard, F. Pociot, J. H. Nielsen, T. Mandrup-Poulsen, J. Nerup, and N. Billestrup
Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity
PNAS,
October 9, 2001;
98(21):
12191 - 12196.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Diabetes Association.
|
|
| |
|